Retrospective assessment of dobutamine therapy for hypotension in anesthetized horses.

The research study presents an evaluation of the use of dobutamine, a drug, in the treatment of low blood pressure in anesthetized horses. The majority of the studied horses responded positively to the treatment, despite some side effects like heart arrhythmias.

Study Methodology

• The study focused on 200 horses that were anesthetized. The purpose of the research was to assess the effectiveness of dobutamine infusion for the treatment of hypotension (low blood pressure).
• The horses were first premedicated with xylazine, another drug that is commonly used as a sedative and muscle relaxant in animals.
• The anesthesia was then induced with guaifenesin and ketamine, two drugs commonly used in veterinary medicine for their anesthetic effects, and was maintained using halothane, an inhalant anesthetic.
• Dobutamine was then administered at a rate of 1.7 micrograms per kilogram of body weight per minute.

Findings

• Out of the 200 horses, 157 (which is 79% of the total) showed a positive response to the dobutamine treatment. This was gauged by an average increase in systolic blood pressure of at least 10 mm Hg within 10 minutes of the infusion.
• The study, however, also reported the emergence of cardiac arrhythmia, or irregular heartbeat, in 56 horses (28%) following the administration of dobutamine. This included 34 cases of sinus bradycardia (slow heartbeat), 18 cases of atrioventricular block (disrupted signals between the heart’s chambers), 2 cases of premature atrial contractions (early heartbeat), and 2 cases of atrioventricular dissociation (disruption in the coordination between the atria and the ventricles).

Conclusion

• Based on these findings, the research concludes that dobutamine intravenous infusion represents an effective treatment for low blood pressure in horses who have been anesthetized with halothane.
• The researchers also highlight the emergence of cardiac arrhythmias as a potential side effect of dobutamine administration in this context, suggesting a need for further investigation and possible measures to mitigate these side effects.